Amlodipine Besylate

CAS 111470-99-6 32 current records 8 historicalSmall Molecule

Who holds supplier records for Amlodipine Besylate? 32 organisations hold a current record for Amlodipine Besylate: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 24 of them hold a valid EU Certificate of Suitability (25 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (21), United States (2), Hungary (2), Spain (1) and 3 other countries (3); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Amlodipine Besylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amlodipine-besylate

Reading the evidence

  • 32 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    21 of the 29 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 21 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (32)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Amlodipine Besylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Amlodipine Besylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (25)

Certificates of Suitability on the EDQM register for Amlodipine Besylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 53 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
RAGHAVA LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2023-350 - Rev 01
Amlodipine besilate
Sept 2026—
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2019-310 - Rev 03
Amlodipine besilate
Sept 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2025-407 - Rev 01
Amlodipine besilate, Site-II
Sept 2026—
SMRUTHI ORGANICS LIMITED SolapurIN
CEP 2023-393 - Rev 01
Amlodipine besilate
Jun 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2006-119 - Rev 07
Amlodipine besilate
May 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2006-130 - Rev 06
Amlodipine besilate
Mar 2026—
KOPRAN RESEARCH LABORATORIES LIMITED MumbaiIN
CEP 2021-242 - Rev 01
Amlodipine besilate
Mar 2026—
MOEHS IBERICA S.L. RubiES
CEP 2021-359 - Rev 03
Amlodipine besilate, M02
Mar 2026—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2025-166 - Rev 01
Amlodipine besilate, TY 45
Mar 2026—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2024-371 - Rev 01
Amlodipine besilate, ADP process
Feb 2026—
EGIS Pharmaceuticals PLC Budapest XHU
CEP 2023-411 - Rev 01
Amlodipine besilate, Synthesis B process B
Feb 2026Inspected Nov 2025
Hungary
NOVARTIS PHARMA AG BaselCH
CEP 2008-122 - Rev 03
Amlodipine besilate, Process II
Feb 2026Inspected Dec 2025
Switzerland
CIPLA LIMITED MumbaiIN
CEP 2015-140 - Rev 02
Amlodipine besilate, Process II
Feb 2026—
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2020-371 - Rev 05
Amlodipine besilate, Process-I
Dec 2025—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2016-282 - Rev 01
Amlodipine besilate, Micronised and non-micronised
Nov 2025Inspected May 2026
Italy
VIATRIS SPECIALTY LLC MorgantownUS
CEP 2021-215 - Rev 01
Amlodipine besilate, Process C
Jan 2024—
GLOCHEM INDUSTRIES PRIVATE LIMITED HyderabadIN
CEP 2002-072 - Rev 10
Amlodipine besilate
Oct 2023—
IPCA Laboratories Limited MumbaiIN
R0-CEP 2023-139 - Rev 00
Amlodipine besilate, AK4 process
Jul 2023—
KRKA, d.d., Novo mesto Novo mestoSI
R0-CEP 2022-449 - Rev 00
Amlodipine besilate, 311302
Jan 2023—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2010-318 - Rev 01
Amlodipine besilate, RTML process
Aug 2022—
ZYDUS LIFESCIENCES LIMITED AnkleshwarIN
R1-CEP 2007-280 - Rev 08
Amlodipine besilate
Jul 2022—
CHANGZHOU RUIMING PHARMACEUTICAL CO., LTD. Chunjiang TownCN
R1-CEP 2008-074 - Rev 01
Amlodipine besilate
Mar 2022—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R1-CEP 2007-293 - Rev 02
Amlodipine besilate
Feb 2021—
ESTEVE QUIMICA S.A. BarcelonaES
R1-CEP 2008-073 - Rev 02
Amlodipine besilate
Oct 2020—
EGIS Pharmaceuticals PLC BudapestHU
R1-CEP 2007-185 - Rev 02
Amlodipine besilate, Synthetic route B
Dec 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Amlodipine Besylate are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 28351 · filed Jun 2014
  • China · Inactive DMF 26132 · filed May 2012
  • ALP PHARM BEIJING CO LTD
    Inactive DMF 21951 · filed Sept 2008
  • EOS ECZACIBASI OZGUN KIMYASAL URUNLER SANAYI VE TICARET AS
    Inactive DMF 20277 · filed Feb 2007
  • China · Inactive DMF 19043 · filed Dec 2005
  • Netherlands · Inactive DMF 18872 · filed Oct 2005
  • MYLAN LABORATORIES LTD
    Inactive DMF 17211, 18503 · filed Jul 2005
  • Slovenia · Inactive DMF 16887 · filed Oct 2003

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Amlodipine Besylate is a calcium channel blocker used to treat high blood pressure and angina. By relaxing blood vessels, it helps improve blood flow and reduce the heart's workload.

Chemical identity

IUPAC name
benzenesulfonic acid;3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES
CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O
InChIKey
ZPBWCRDSRKPIDG-UHFFFAOYSA-N
Synonyms
amlessa component amlodipine besylate, amlodipine (as besilate), amlodipine benzenesulfonate, amlodipine besilate, amlor, amturnide component amlodipine besylate, antacal, azor component amlodipine besylate, caduet component amlodipine besylate, consensi component amlodipine besylate, copalia component amlodipine besylate, dafiro component amlodipine besilate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists; Cytochrome P450 3A Inhibitors
Chemical structure
Dihydropyridines

Therapeutic areas

CardiovascularHypertensionAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Amlodipine Besylate?

32 organisations hold an active US FDA Type II Drug Master File or a CEP for Amlodipine Besylate: GLOCHEM INDUSTRIES LTD (India), Unichem Laboratories Ltd. (India), Zydus Lifesciences Limited (India), APITORIA PHARMA PRIVATE LTD (India), Arene Life Sciences Limited (India), Aurore Life Sciences (India), Cadila Pharmaceuticals Limited (India) and Cipla Limited (India), and 24 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Amlodipine Besylate Drug Master Files are active?

GLOCHEM INDUSTRIES LTD (DMF 24942, 19591), Unichem Laboratories Ltd. (DMF 40438, 16509), Zydus Lifesciences Limited (DMF 22930, 18827), APITORIA PHARMA PRIVATE LTD (DMF 18965), Arene Life Sciences Limited (DMF 33873, 35997), Aurore Life Sciences (DMF 34318), Cadila Pharmaceuticals Limited (DMF 16911) and Cipla Limited (DMF 17032) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Amlodipine Besylate records mean?

8 organisations have only inactive Type II DMFs for Amlodipine Besylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Amlodipine Besylate have a European Certificate of Suitability?

Yes. 24 organisations hold a valid CEP for Amlodipine Besylate on the EDQM register, including RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), HETERO DRUGS LIMITED Hyderabad (IN), SMRUTHI ORGANICS LIMITED Solapur (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 19 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Amlodipine Besylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Amlodipine Besylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.